CH640727A5 - Tablet or other solid, compressed article - Google Patents
Tablet or other solid, compressed article Download PDFInfo
- Publication number
- CH640727A5 CH640727A5 CH336478A CH336478A CH640727A5 CH 640727 A5 CH640727 A5 CH 640727A5 CH 336478 A CH336478 A CH 336478A CH 336478 A CH336478 A CH 336478A CH 640727 A5 CH640727 A5 CH 640727A5
- Authority
- CH
- Switzerland
- Prior art keywords
- tablet
- substance
- brittle
- solid
- wax
- Prior art date
Links
- 239000007787 solid Substances 0.000 title claims description 28
- 239000000126 substance Substances 0.000 claims description 71
- 239000003094 microcapsule Substances 0.000 claims description 37
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical group [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 26
- 239000011248 coating agent Substances 0.000 claims description 21
- 238000000576 coating method Methods 0.000 claims description 21
- 238000000465 moulding Methods 0.000 claims description 14
- 239000001103 potassium chloride Substances 0.000 claims description 13
- 235000011164 potassium chloride Nutrition 0.000 claims description 13
- 238000002844 melting Methods 0.000 claims description 10
- 230000008018 melting Effects 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 239000000969 carrier Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000002202 Polyethylene glycol Substances 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 5
- 239000011159 matrix material Substances 0.000 claims description 5
- 239000000645 desinfectant Substances 0.000 claims description 3
- 239000002934 diuretic Substances 0.000 claims description 2
- 230000001882 diuretic effect Effects 0.000 claims description 2
- 239000003337 fertilizer Substances 0.000 claims description 2
- 235000015097 nutrients Nutrition 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 239000000575 pesticide Substances 0.000 claims description 2
- 239000002831 pharmacologic agent Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 description 56
- 239000001993 wax Substances 0.000 description 12
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000000843 powder Substances 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 239000008108 microcrystalline cellulose Substances 0.000 description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 2
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229920001429 chelating resin Polymers 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 238000005245 sintering Methods 0.000 description 2
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical class [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000012431 wafers Nutrition 0.000 description 2
- 238000005550 wet granulation Methods 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- OAZOBYBYAKXURF-UHFFFAOYSA-N 2-(sulfamoylamino)benzoic acid Chemical compound NS(=O)(=O)NC1=CC=CC=C1C(O)=O OAZOBYBYAKXURF-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical class OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000009500 colour coating Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- -1 polyethylene glycol Chemical class 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 239000007885 tablet disintegrant Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000004149 tartrazine Substances 0.000 description 1
- UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 description 1
- 229960000943 tartrazine Drugs 0.000 description 1
- 235000012756 tartrazine Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- General Preparation And Processing Of Foods (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB13855/77A GB1598458A (en) | 1977-04-01 | 1977-04-01 | Tableting of microcapsules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH640727A5 true CH640727A5 (en) | 1984-01-31 |
Family
ID=10030606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH336478A CH640727A5 (en) | 1977-04-01 | 1978-03-29 | Tablet or other solid, compressed article |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS53142520A (en, 2012) |
| AU (1) | AU523028B2 (en, 2012) |
| BE (1) | BE865633A (en, 2012) |
| CA (1) | CA1110972A (en, 2012) |
| CH (1) | CH640727A5 (en, 2012) |
| DE (1) | DE2813146A1 (en, 2012) |
| DK (1) | DK143078A (en, 2012) |
| FR (1) | FR2385388B1 (en, 2012) |
| GB (1) | GB1598458A (en, 2012) |
| IT (1) | IT1095559B (en, 2012) |
| NL (1) | NL7803496A (en, 2012) |
| SE (1) | SE7803661L (en, 2012) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5873359A (ja) * | 1981-10-27 | 1983-05-02 | 旭化成株式会社 | 医薬錠剤の製造方法 |
| US4749575A (en) * | 1983-10-03 | 1988-06-07 | Bio-Dar Ltd. | Microencapsulated medicament in sweet matrix |
| US4863741A (en) * | 1985-03-25 | 1989-09-05 | Abbott Laboratories | Tablet composition for drug combinations |
| CA1259924A (en) * | 1985-03-25 | 1989-09-26 | Wallace E. Becker | Pharmaceutical tableting method |
| CA1266235A (en) * | 1985-03-25 | 1990-02-27 | Wallace E. Becker | Tablet composition for drug combinations |
| DE3532692A1 (de) * | 1985-09-13 | 1987-03-19 | Boehringer Mannheim Gmbh | Verfahren zum herstellen von tabletten aus pellets |
| WO1987006129A1 (en) * | 1986-04-10 | 1987-10-22 | Daratech Pty. Ltd. | Vaccine and implant |
| US6024983A (en) * | 1986-10-24 | 2000-02-15 | Southern Research Institute | Composition for delivering bioactive agents for immune response and its preparation |
| US5009897A (en) * | 1988-06-24 | 1991-04-23 | Abbott Laboratories | Pharmaceutical granules and tablets made therefrom |
| JP2514078B2 (ja) * | 1988-08-22 | 1996-07-10 | エスエス製薬株式会社 | 圧縮成型製剤 |
| WO1990007327A1 (en) * | 1988-12-28 | 1990-07-12 | Taisho Pharmaceutical Co., Ltd. | Stress scattering method in tableting |
| DE3933000A1 (de) * | 1989-10-03 | 1991-04-11 | Int Pharma Agentur | Erosionsgesteuertes wirkstoff-freigabesystem und verfahren zu seiner herstellung |
| EP0418596A3 (en) * | 1989-09-21 | 1991-10-23 | American Cyanamid Company | Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form |
| US5281420A (en) * | 1992-05-19 | 1994-01-25 | The Procter & Gamble Company | Solid dispersion compositions of tebufelone |
| US5436011A (en) * | 1993-04-16 | 1995-07-25 | Bristol-Myers Squibb Company | Solid pharmaceutical dosage form and a method for reducing abrasion |
| US5631024A (en) * | 1995-05-22 | 1997-05-20 | Enviroquest, Ltd. | Medicaments for beneficial insects and method |
| GB9921933D0 (en) * | 1999-09-17 | 1999-11-17 | Univ Gent | Solid shaped articles comprising biologically active substances and a method for their production |
| US6419954B1 (en) * | 2000-05-19 | 2002-07-16 | Yamanouchi Pharmaceutical Co., Ltd. | Tablets and methods for modified release of hydrophilic and other active agents |
| CN1315638C (zh) * | 2000-06-20 | 2007-05-16 | 株式会社三和化学研究所 | 有核成型品及其制造方法和装置 |
| AU6786001A (en) | 2000-07-05 | 2002-01-14 | Asahi Chemical Ind | Cellulose powder |
| US7914804B2 (en) | 2000-09-01 | 2011-03-29 | Palmaya Pty Ltd | Slow release pharmaceutical preparation and method of administering same |
| US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| US20030190343A1 (en) * | 2002-03-05 | 2003-10-09 | Pfizer Inc. | Palatable pharmaceutical compositions for companion animals |
| FR2837100B1 (fr) | 2002-03-18 | 2004-07-23 | Flamel Tech Sa | Comprimes a bases de microcapsules a liberation modifiee |
| FR2838647B1 (fr) * | 2002-04-23 | 2006-02-17 | Particules enrobees a liberation prolongee, leur procede de preparation et comprimes les contenant | |
| US20060263429A1 (en) | 2005-05-20 | 2006-11-23 | Hengsheng Feng | Compressible mixture, compressed pharmaceutical compositions, and method of preparation thereof |
| SA07280459B1 (ar) | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
| US20110287091A1 (en) * | 2009-01-22 | 2011-11-24 | Abbot Healthcare Private Limited | Chronotherapeutic pharmaceutical composition |
| EP3043779B1 (en) * | 2013-09-13 | 2018-05-16 | R.P. Scherer Technologies, LLC | Encased-pellet tablets |
| CN112490052A (zh) | 2020-11-19 | 2021-03-12 | 深圳市致尚科技股份有限公司 | 多方向输入装置 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE575775A (en, 2012) * | 1958-02-18 | |||
| SE363974B (en, 2012) * | 1964-05-20 | 1974-02-11 | Bristol Myers Co | |
| AU418370B2 (en) * | 1965-05-11 | 1971-11-02 | Compositions for anorectic use | |
| US3487138A (en) * | 1966-11-23 | 1969-12-30 | Merck & Co Inc | Process for preparing a delayed release medicinal tablet |
| DE1617363B1 (de) * | 1967-12-06 | 1972-05-31 | Boehringer & Soehne Gmbh | Verfahren zur Herstellung hochaktiver Enzym-Verdauungspraeparate |
| US3557279A (en) * | 1969-06-12 | 1971-01-19 | Merck & Co Inc | Microencapsulation form of an anti-inflammatory drug |
| NL7112083A (en, 2012) * | 1970-09-16 | 1972-03-20 |
-
1977
- 1977-04-01 GB GB13855/77A patent/GB1598458A/en not_active Expired
-
1978
- 1978-03-25 DE DE19782813146 patent/DE2813146A1/de not_active Withdrawn
- 1978-03-29 CH CH336478A patent/CH640727A5/de not_active IP Right Cessation
- 1978-03-30 IT IT21797/78A patent/IT1095559B/it active
- 1978-03-31 NL NL7803496A patent/NL7803496A/xx not_active Application Discontinuation
- 1978-03-31 DK DK143078A patent/DK143078A/da not_active Application Discontinuation
- 1978-03-31 JP JP3874478A patent/JPS53142520A/ja active Pending
- 1978-03-31 FR FR7809666A patent/FR2385388B1/fr not_active Expired
- 1978-03-31 AU AU34651/78A patent/AU523028B2/en not_active Expired
- 1978-03-31 SE SE7803661A patent/SE7803661L/xx unknown
- 1978-03-31 CA CA300,184A patent/CA1110972A/en not_active Expired
- 1978-04-03 BE BE186523A patent/BE865633A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2385388A1 (en, 2012) | 1978-10-27 |
| AU523028B2 (en) | 1982-07-08 |
| GB1598458A (en) | 1981-09-23 |
| IT1095559B (it) | 1985-08-10 |
| DE2813146A1 (de) | 1978-10-19 |
| FR2385388B1 (en, 2012) | 1980-07-25 |
| JPS53142520A (en) | 1978-12-12 |
| DK143078A (da) | 1978-10-02 |
| AU3465178A (en) | 1979-10-04 |
| CA1110972A (en) | 1981-10-20 |
| IT7821797A0 (it) | 1978-03-30 |
| SE7803661L (sv) | 1978-10-02 |
| BE865633A (fr) | 1978-10-03 |
| NL7803496A (nl) | 1978-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH640727A5 (en) | Tablet or other solid, compressed article | |
| DE2950977C2 (en, 2012) | ||
| DE69532031T2 (de) | Schilddrüsenhormone enthaltende mittel | |
| DE69821553T2 (de) | Granulatzubereitung enthaltend Simethicon und granuliertes wasserfreies Calciumphosphat | |
| DE2636152C2 (de) | Verfahren zur Herstellung von Dragees | |
| AT394310B (de) | Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge | |
| DE1492107A1 (de) | Verfahren zur Herstellung einer Tablette | |
| EP0122219A2 (de) | Resinat einer substituierten Carbonsäure, Verfahren zu seiner Herstellung, seine Verwendung und dieses enthaltende pharmazeutische Präparate | |
| DE2224534A1 (de) | Pharmazeutisches Präparat mit langsamer Wirkstoffabgabe | |
| DE1492208A1 (de) | Tablettenherstellungsverfahren | |
| DE2658309A1 (de) | Arzneipraeparat fuer die orale verabreichung und verfahren zu seiner herstellung | |
| EP0250648B1 (de) | Pharmazeutisches Präparat zur verzögerten Freigabe von Ibuprofen | |
| CH665124A5 (de) | Verfahren zur herstellung von tabletten mit regulierter wirkstoffabgabe. | |
| DE1292783B (de) | Verfahren zum Herstellen einer Tablette mit Depotwirkung | |
| DE1467906A1 (de) | Verfahren zur Herstellung von sich langsam loesenden Tabletten | |
| DE2020620A1 (de) | Traeger fuer das unmittelbare Komprimieren von Tabletten | |
| DE69813872T2 (de) | Komplex aus carrageenan und einem wasserlöslichen medikament mit einer spezifischen granulometrie und entsprechende pharmazeutische zusammensetzungen mit gesteuerter freisetzung | |
| DE1298237B (de) | Verfahren zur Herstellung von Tabletten aus therapeutischem gepulvertem Material ohne vorheriges Granulieren | |
| DE68912515T2 (de) | Granulierungsmittel und Verfahren. | |
| DE2706660A1 (de) | Ascorbinsaeure enthaltende granulate und verfahren zu ihrer herstellung | |
| DE1542340A1 (de) | Verfahren zur UEberfuehrung fein zerteilter,fester Substanzen in frei fliessende Form | |
| DE2900304C3 (de) | Saponinextraktprodukt sowie Verfahren zu seiner Herstellung | |
| EP0615450B1 (de) | Dimeticon-pastillen | |
| EP1135147B1 (de) | Verfahren zur herstellung von arzneimitteln in fester darreichungsform aus pflanzlichen extrakten | |
| DE2129646C3 (de) | Verfahren zur Herstellung von Tabletten einheitlicher Form und einheitlicher Größe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |